$AGEN
Agenus Inc.
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$6.96
▲+4.27%+$0.285Market open
Agenus Inc.
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is AGEN up today? It is at $6.96 (+4.27%), and our scanner flagged it 102 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment AGEN spikes, and full due diligence on AGEN — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $AGEN 102 times in the last 30 days. Create a free account to track $AGEN, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on AGEN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for AGEN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystMaterial Agreement · New Financial Obligation, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Oct 2, 2026 · 32 days agoAcross every filing on file, supply equal to at least 44.8% of the tradeable float is in play - 44.8% more can still be issued.
Some filings did not state a size, so these are floors.
Shelf sizes are dollars, so shares are estimated at today's price.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
At-the-market (ATM) program — sells new shares into the market gradually over time · About $85.0M in size
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Harrison Thomas L Director | Acquired (grant/award) | +4K | added 9.3% | 52K | $31K at $6.89 | Oct 1, 26 |
Armen Garo H Officer | Acquired (grant/award) | +5K 0.01% of company | added 1.3% | 371K | $16K at $3.35 | Jul 10, 26 |
Harrison Thomas L Director | Acquired (grant/award) | +9K 0.02% of company | added 22% | 48K | $31K at $3.58 | Jul 1, 26 |
Armen Garo H Officer | Acquired (grant/award) | +5K 0.01% of company | added 1.5% | 366K | $16K at $3.03 | Jun 26, 26 |
Armen Garo H Officer | Acquired (grant/award) | +5K 0.01% of company | added 1.4% | 361K | $16K at $3.30 | Jun 12, 26 |
Armen Garo H Officer | Acquired (grant/award) | +5K 0.01% of company | added 1.3% | 356K | $16K at $3.50 | May 29, 26 |
Armen Garo H Officer | Acquired (grant/award) | +5K 0.01% of company | added 1.3% | 351K | $16K at $3.58 | May 15, 26 |
Armen Garo H Officer | Acquired (grant/award) | +4K | added 1.2% | 347K | $16K at $3.84 | May 1, 26 |
Armen Garo H Officer | Acquired (grant/award) | +3K | added 1.0% | 343K | $16K at $4.79 | Apr 17, 26 |
Armen Garo H Officer | Acquired (grant/award) | +5K 0.01% of company | added 1.4% | 339K | $15K at $3.33 | Apr 3, 26 |
Harrison Thomas L Director | Acquired (grant/award) | +9K 0.02% of company | added 31% | 39K | $31K at $3.32 | Apr 1, 26 |
Armen Garo H Officer | Acquired (grant/award) | +4K | added 1.2% | 335K | $15K at $3.71 | Mar 20, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on AGEN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for AGEN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
AGEN last traded at $6.96, up 4.27% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Agenus Inc. (AGEN) is next expected to report earnings on Thursday, November 5, 2026 (before open), which is tomorrow. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The AGEN Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged AGEN 102 times in the last 30 days.
AGEN (Agenus Inc.) trades on XNAS, with a market cap of about $300M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge AGEN for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$AGEN discussion
Sign in to ask a question or join the discussion.